Clinical trial NCT05937425: The Effect of Nurse Navigation Program on Lung Cancer Patients
Official title: The Effect of Nurse Navigation Program Applied in Line With Supportive Care Needs in Patients Diagnosed With Lung Cancer on Anxiety-Depression, Adaptation to the Disease and Quality of Life
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Non Small Cell Lung Cancer
Keywords: Cancer
Nurse Navigator
Nurse Navigation Program
Individualized Care
Anxiety-Depression
Adaptation to the Disease
Quality of Life
Lead sponsor: Akdeniz University
Sponsor class: OTHER
First posted: 2023-07-10
Enrollment: 84
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: This is a randomized controlled trial consisting of two groups: experimental and control.
Primary purpose: SUPPORTIVE_CARE

Brief summary: The study aims to determine the effect of the nurse navigation program (LungCaNN), which is performed in line with the supportive care needs of newly diagnosed non-small cell lung cancer patients, on the level of anxiety-depression, adherence to the disease, and quality of life.

The study was designed as a randomized study with a control group. This study will be carried out with a total of 84 NSCLC patients, 42 of whom were in the intervention group and 42 in the control group, whose treatment was started in Akdeniz University Medical Oncology Outpatient Clinic and met the inclusion criteria of the sampling. Nurse navigation program will be applied for 12 weeks from the diagnosis of NSCLC patients in the intervention group. The intervention protocol of the study is abbreviated as "Lung Cancer Nurse Navigator" \[LungCaNN\].

Within the scope of the LungCaNN program, face-to-face patient education, patient education booklet, face-to-face, and telephone navigation initiatives were planned. Patient Identification Form, Depression Anxiety Stress Scale (DASS 21), Chronic Disease Adjustment Scale, EORTC QLQ 30 Quality of Life Scale-/ LC-13, and Navigation and Interview Steps Form will be used to collect data.


Eligibility criteria: Inclusion Criteria:

* Know how to read and write No hearing or speech problems Be able to use the phone The primary medical diagnosis is non-small cell lung cancer Karnofsky Performance Scale score of 70% or higher Patients with a stress thermometer of 4 and above At most six weeks past the date of diagnosis

Exclusion Criteria:

* Patients with cognitive problems Expected life expectancy is less than three months

Primary outcomes:
measure: Depression, Stress, Anxiety Scale (DASS21)
timeFrame: change from baseline DASS21 at 12 week
measure: EORTC QLQ - C30 Quality of Life Scale/ LC-13 Lung Module
timeFrame: change from baseline EORTC QLQ - C30 Quality of Life Scale/ LC-13 Lung Module at 12 week
measure: Scale of Adjustment to Chronic Diseases
timeFrame: change from baseline Scale of Adjustment to Chronic Diseases at 12 week
Secondary outcomes:
Other outcomes:
Locations:
city: Konyaaltı
country: Turkey
facility: Akdeniz University
state: Antalya
Study officials:
affiliation: Akdeniz University
name: Fatma Arikan, PhD, RN
role: STUDY_DIRECTOR
References: